Important Safety Information and Indications
LEVOXYL is indicated for hypothyroidism—as replacement or supplemental therapy in congenital or acquired hypothyroidism of any etiology, except transient hypothyroidism during the recovery phase of subacute thyroiditis. Specific indications include: primary (thyroidal), secondary (pituitary), and tertiary (hypothalamic) hypothyroidism and subclinical hypothyroidism.
LEVOXYL is indicated for pituitary TSH suppression—in the treatment or prevention of various types of euthyroid goiters including thyroid nodules, subacute or chronic lymphocytic thyroiditis (Hashimoto’s thyroiditis) multinodular goiter and as an adjunct to surgery and radioiodine therapy in the management of thyrotropin-dependent well-differentiated thyroid cancer.
LEVOXYL Cost and Coverage
As of March 2016, LEVOXYL Has a Less Expensive Average Co-pay Than Other Branded Hypothyroid Medications1*
The average brand-name LEVOXYL co-pay cost is*:
- ~50% less than the average Synthroid co-pay cost1
- ~$5 more than the average generic levothyroxine co-pay cost